Skip to main content
. 2019 Nov 29;9:17980. doi: 10.1038/s41598-019-52971-3

Figure 2.

Figure 2

IDET suppresses the proliferation of multiple breast cancer cells in a dose- and time- dependent manner. Breast cancer cell lines (T47D, MCF-7, MDA-MB-468, MDA-MB-453) were exposed to (A) different concentrations of IDET for 72 hrs or (B) 25 µM IDET for 24–72 hrs. The proliferation of cells was assessed by measuring the mitochondrial reductase activity. The values indicate mean ± SE (3 experiments). *Shows the significance level in comparison to untreated group; P < 0.05. IDET, isodeoxyelephantopin.